Published in Int Urol Nephrol on February 04, 2017
Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med (2015) 8.38
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int (2011) 4.51
Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial. J Am Coll Cardiol (2015) 2.74
Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet (2010) 2.65
Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol (2007) 2.43
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. Thromb Haemost (2014) 2.29
Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis (2009) 2.21
Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol (2009) 2.13
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor. Thromb Haemost (2012) 1.77
Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study. Ann Pharmacother (2012) 1.74
Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant (2013) 1.65
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract (2010) 1.62
Structure-based design of novel potent nonpeptide thrombin inhibitors. J Med Chem (2002) 1.51
Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin. Ann Emerg Med (2013) 1.45
AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol (2011) 1.40
Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies. J Thromb Haemost (2008) 1.38
Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis. Am J Kidney Dis (2000) 1.31
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol (2011) 1.17
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol (2006) 1.08
Edoxaban: a new oral direct factor xa inhibitor. Drugs (2011) 1.02
Endothelial cytoskeletal reorganization in response to PAR1 stimulation is mediated by membrane rafts but not caveolae. Am J Physiol Heart Circ Physiol (2007) 1.01
Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury. Nephrol Dial Transplant (2010) 1.00
The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients. PLoS One (2013) 0.97
Acute reversible renal failure with macroscopic haematuria in IgA nephropathy. Nephrol Dial Transplant (1993) 0.96
Dabigatran and kidney disease: a bad combination. Clin J Am Soc Nephrol (2013) 0.95
Haematuria: the forgotten CKD factor? Nephrol Dial Transplant (2012) 0.91
Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract (2012) 0.91
Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin. Clin Kidney J (2013) 0.89
Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int (1985) 0.87
Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost (2015) 0.84
Role of thrombin receptors in the kidney: lessons from PAR1 knock-out mice. Nephrol Dial Transplant (2001) 0.83
A case of dabigatran-associated acute renal failure. WMJ (2013) 0.81
Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis. Pharmacoepidemiol Drug Saf (2015) 0.78
Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study. Can J Cardiol (2016) 0.77
The Spectrum of Infectious Diseases in Kidney Transplantation: A Review of the Classification, Pathogens and Clinical Manifestations. In Vivo (2015) 0.78
Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease. Int Urol Nephrol (2016) 0.75
Nodular glomerulosclerosis: not always diabetic nephropathy. Minerva Med (2017) 0.75
"Diabetic nephropathy" in a non-diabetic patient. Pathol Res Pract (2016) 0.75